Business Description
Microbix Biosystems Inc
NAICS : 325414
SIC : 3741
ISIN : CA59501P1045
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.92 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 1.06 | |||||
Interest Coverage | 1.51 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 3.06 | |||||
Beneish M-Score | -1.5 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.3 | |||||
3-Year EPS without NRI Growth Rate | 14.7 | |||||
3-Year FCF Growth Rate | -23.3 | |||||
3-Year Book Growth Rate | 43.4 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.03 | |||||
9-Day RSI | 46.29 | |||||
14-Day RSI | 44.7 | |||||
6-1 Month Momentum % | 13.56 | |||||
12-1 Month Momentum % | -15.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.64 | |||||
Quick Ratio | 4.98 | |||||
Cash Ratio | 3.46 | |||||
Days Inventory | 207.83 | |||||
Days Sales Outstanding | 57.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8 | |||||
Shareholder Yield % | 0.44 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.38 | |||||
Operating Margin % | 5.75 | |||||
Net Margin % | 17.04 | |||||
FCF Margin % | 7.74 | |||||
ROE % | 16.16 | |||||
ROA % | 11.42 | |||||
ROIC % | 6.51 | |||||
ROC (Joel Greenblatt) % | 30.92 | |||||
ROCE % | 15.71 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 10.67 | |||||
Forward PE Ratio | 16.26 | |||||
PE Ratio without NRI | 10.67 | |||||
Price-to-Owner-Earnings | 12.31 | |||||
PS Ratio | 1.86 | |||||
PB Ratio | 1.58 | |||||
Price-to-Tangible-Book | 1.91 | |||||
Price-to-Free-Cash-Flow | 24.62 | |||||
Price-to-Operating-Cash-Flow | 16 | |||||
EV-to-EBIT | 7.75 | |||||
EV-to-EBITDA | 6.05 | |||||
EV-to-Revenue | 1.62 | |||||
EV-to-Forward-Revenue | 1.32 | |||||
EV-to-FCF | 20.5 | |||||
Price-to-Projected-FCF | 1.91 | |||||
Price-to-Median-PS-Value | 0.68 | |||||
Price-to-Graham-Number | 0.96 | |||||
Price-to-Net-Current-Asset-Value | 2.95 | |||||
Price-to-Net-Cash | 16.25 | |||||
Earnings Yield (Greenblatt) % | 12.91 | |||||
FCF Yield % | 4.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Microbix Biosystems Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 23.835 | ||
EPS (TTM) (C$) | 0.03 | ||
Beta | 0.69 | ||
Volatility % | 44.01 | ||
14-Day RSI | 44.7 | ||
14-Day ATR (C$) | 0.0089 | ||
20-Day SMA (C$) | 0.33025 | ||
12-1 Month Momentum % | -15.19 | ||
52-Week Range (C$) | 0.23 - 0.45 | ||
Shares Outstanding (Mil) | 137.42 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Microbix Biosystems Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Microbix Biosystems Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Microbix Biosystems Inc Frequently Asked Questions
What is Microbix Biosystems Inc(TSX:MBX)'s stock price today?
When is next earnings date of Microbix Biosystems Inc(TSX:MBX)?
Does Microbix Biosystems Inc(TSX:MBX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |